TY  - GEN
AU  - Josting,A
AU  - Rudolph,C
AU  - Mapara,M
AU  - Glossmann,J-P
AU  - Sieniawski,M
AU  - Sienawski,M
AU  - Sieber,M
AU  - Kirchner,H H
AU  - Dörken,B
AU  - Hossfeld,D K
AU  - Kisro,J
AU  - Metzner,B
AU  - Berdel,W E
AU  - Diehl,V
AU  - Engert,A
TI  - Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)
SN  - 0923-7534
PY  - 2005///0428
KW  - Adolescent
KW  - Adult
KW  - Antineoplastic Agents, Alkylating
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Carmustine
KW  - Cisplatin
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Cytarabine
KW  - Dexamethasone
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Etoposide
KW  - Female
KW  - Granulocyte Colony-Stimulating Factor
KW  - Hodgkin Disease
KW  - drug therapy
KW  - Humans
KW  - Infusions, Intravenous
KW  - Injections, Subcutaneous
KW  - Male
KW  - Melphalan
KW  - Methotrexate
KW  - Middle Aged
KW  - Peripheral Blood Stem Cell Transplantation
KW  - Recurrence
KW  - Treatment Outcome
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1093/annonc/mdi003
ER  -